(MedPage Today) — Andexanet alfa (Andexxa) will officially be taken off the U.S. market this month as an emergency reversal medication for contemporary blood thinners.
“The Biologics License Application for Andexxa has been withdrawn for commercial…
vivo launches P149k production-ready flagship camera phone, here’s why it’s worth it
The kit transforms the smartphone into a production-ready rig with 200mm and 400mm telephoto extenders, a professional grip, tripod collar...






